{"id":8488,"date":"2024-02-26T23:18:36","date_gmt":"2024-02-26T15:18:36","guid":{"rendered":"https:\/\/flcube.com\/?p=8488"},"modified":"2024-10-21T23:22:30","modified_gmt":"2024-10-21T15:22:30","slug":"fujian-province-issues-provisional-regulations-for-managing-medical-representative-visits","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=8488","title":{"rendered":"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits"},"content":{"rendered":"\n<p>The Fujian provincial health commission and medical products administration have jointly issued the &#8220;Provisional Regulations on the Management of Reception of Medical Representatives by Staff of Public Medical Institutions in Fujian Province.&#8221; These regulations mandate that pharmaceutical representatives engaging in academic promotion activities related to their products within medical institutions must first register and file with the institution&#8217;s pharmaceutical department, equipment department, and other relevant drug and medical device management departments. They are also required to report to the medical institution office (or a designated department) for centralized management. In principle, each pharmaceutical representative should register at least once a year, with unregistered representatives prohibited from conducting academic promotion activities within medical institutions. Representatives hired or authorized by enterprises must register on the designated filing platform of the National Medical Products Administration in accordance with the &#8220;Administrative Measures for the Filing of Medical Representatives (Trial)&#8221; and those not filed will not be registered for documentation.<\/p>\n\n\n\n<p>Medical institutions are directed to establish a reception management system adhering to the &#8220;three fixed and two available&#8221; principle (fixed reception time, fixed reception location, fixed reception personnel, available reception process, and available reception record) for appointment-based reception. Institutions should establish a relatively fixed monthly reception day for pharmaceutical enterprises, which should be announced publicly. Representatives can only conduct academic promotion activities on the designated reception day. For special circumstances requiring activities on non-reception days, prior review by the medical institution is mandatory. Representatives must make appointments with relevant departments in advance, and institutions should verify their identity. Those without advance appointments or unverified identity information will not be accepted. Management personnel are required to conduct periodic inspections in clinical, medical technology departments, and relevant functional departments.- <a href=\"https:\/\/flcube.com\">Flcube.com<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Fujian provincial health commission and medical products administration have jointly issued the &#8220;Provisional Regulations&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[60,14],"class_list":["post-8488","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nhc-nhfpc","tag-nmpa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Fujian provincial health commission and medical products administration have jointly issued the &quot;Provisional Regulations on the Management of Reception of Medical Representatives by Staff of Public Medical Institutions in Fujian Province.&quot; These regulations mandate that pharmaceutical representatives engaging in academic promotion activities related to their products within medical institutions must first register and file with the institution&#039;s pharmaceutical department, equipment department, and other relevant drug and medical device management departments. They are also required to report to the medical institution office (or a designated department) for centralized management. In principle, each pharmaceutical representative should register at least once a year, with unregistered representatives prohibited from conducting academic promotion activities within medical institutions. Representatives hired or authorized by enterprises must register on the designated filing platform of the National Medical Products Administration in accordance with the &quot;Administrative Measures for the Filing of Medical Representatives (Trial)&quot; and those not filed will not be registered for documentation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=8488\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=8488\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-26T15:18:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-21T15:22:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=8488#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=8488\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits\",\"datePublished\":\"2024-02-26T15:18:36+00:00\",\"dateModified\":\"2024-10-21T15:22:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=8488\"},\"wordCount\":296,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NHC (NHFPC)\",\"NMPA\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=8488#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=8488\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=8488\",\"name\":\"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2024-02-26T15:18:36+00:00\",\"dateModified\":\"2024-10-21T15:22:30+00:00\",\"description\":\"The Fujian provincial health commission and medical products administration have jointly issued the \\\"Provisional Regulations on the Management of Reception of Medical Representatives by Staff of Public Medical Institutions in Fujian Province.\\\" These regulations mandate that pharmaceutical representatives engaging in academic promotion activities related to their products within medical institutions must first register and file with the institution's pharmaceutical department, equipment department, and other relevant drug and medical device management departments. They are also required to report to the medical institution office (or a designated department) for centralized management. In principle, each pharmaceutical representative should register at least once a year, with unregistered representatives prohibited from conducting academic promotion activities within medical institutions. Representatives hired or authorized by enterprises must register on the designated filing platform of the National Medical Products Administration in accordance with the \\\"Administrative Measures for the Filing of Medical Representatives (Trial)\\\" and those not filed will not be registered for documentation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=8488#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=8488\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=8488#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits - Insight, China&#039;s Pharmaceutical Industry","description":"The Fujian provincial health commission and medical products administration have jointly issued the \"Provisional Regulations on the Management of Reception of Medical Representatives by Staff of Public Medical Institutions in Fujian Province.\" These regulations mandate that pharmaceutical representatives engaging in academic promotion activities related to their products within medical institutions must first register and file with the institution's pharmaceutical department, equipment department, and other relevant drug and medical device management departments. They are also required to report to the medical institution office (or a designated department) for centralized management. In principle, each pharmaceutical representative should register at least once a year, with unregistered representatives prohibited from conducting academic promotion activities within medical institutions. Representatives hired or authorized by enterprises must register on the designated filing platform of the National Medical Products Administration in accordance with the \"Administrative Measures for the Filing of Medical Representatives (Trial)\" and those not filed will not be registered for documentation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=8488","og_locale":"en_US","og_type":"article","og_title":"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=8488","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2024-02-26T15:18:36+00:00","article_modified_time":"2024-10-21T15:22:30+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=8488#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=8488"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits","datePublished":"2024-02-26T15:18:36+00:00","dateModified":"2024-10-21T15:22:30+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=8488"},"wordCount":296,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NHC (NHFPC)","NMPA"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=8488#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=8488","url":"https:\/\/flcube.com\/?p=8488","name":"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2024-02-26T15:18:36+00:00","dateModified":"2024-10-21T15:22:30+00:00","description":"The Fujian provincial health commission and medical products administration have jointly issued the \"Provisional Regulations on the Management of Reception of Medical Representatives by Staff of Public Medical Institutions in Fujian Province.\" These regulations mandate that pharmaceutical representatives engaging in academic promotion activities related to their products within medical institutions must first register and file with the institution's pharmaceutical department, equipment department, and other relevant drug and medical device management departments. They are also required to report to the medical institution office (or a designated department) for centralized management. In principle, each pharmaceutical representative should register at least once a year, with unregistered representatives prohibited from conducting academic promotion activities within medical institutions. Representatives hired or authorized by enterprises must register on the designated filing platform of the National Medical Products Administration in accordance with the \"Administrative Measures for the Filing of Medical Representatives (Trial)\" and those not filed will not be registered for documentation.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=8488#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=8488"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=8488#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/8488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8488"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/8488\/revisions"}],"predecessor-version":[{"id":8489,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/8488\/revisions\/8489"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}